Vanda Pharmaceuticals
VNDA
#7861
Rank
โ‚ฌ0.27 B
Marketcap
4,63ย โ‚ฌ
Share price
3.65%
Change (1 day)
1.06%
Change (1 year)

Earnings for Vanda Pharmaceuticals (VNDA)

Earnings in 2025 (TTM): -โ‚ฌ0.11 Billion

According to Vanda Pharmaceuticals's latest financial reports the company's current earnings are โ‚ฌ0.21 Billion. In 2024 the company made an earning of -โ‚ฌ34.93 Million a decrease over its 2023 earnings that were of -โ‚ฌ11.99 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Vanda Pharmaceuticals from 2005 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -โ‚ฌ0.11 Billion206.74%
2024 -โ‚ฌ34.93 Million191.43%
2023 -โ‚ฌ11.99 Million-320.45%
2022 โ‚ฌ5.43 M-84.99%
2021 โ‚ฌ36.21 M54.8%
2020 โ‚ฌ23.39 M19.42%
2019 โ‚ฌ19.59 M4.93%
2018 โ‚ฌ18.67 M-228.6%
2017 -โ‚ฌ14.52 Million-8.98%
2016 -โ‚ฌ15.96 Million-53.79%
2015 -โ‚ฌ34.52 Million-30.18%
2014 -โ‚ฌ49.44 Million173.08%
2013 -โ‚ฌ18.11 Million-25.33%
2012 -โ‚ฌ24.25 Million163.61%
2011 -โ‚ฌ9.2 Million-221.15%
2010 โ‚ฌ7.59 M-124.53%
2009 -โ‚ฌ30.95 Million-29.44%
2008 -โ‚ฌ43.86 Million-36.2%
2007 -โ‚ฌ68.75 Million21.81%
2006 -โ‚ฌ56.44 Million170.55%
2005 -โ‚ฌ20.86 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Novartis
NVS
โ‚ฌ14.10 B-13,658.89%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Eli Lilly
LLY
โ‚ฌ19.32 B-18,683.58%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
โ‚ฌ27.82 B-26,852.77%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
โ‚ฌ6.89 B-6,733.69%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
โ‚ฌ10.17 B-9,887.44%๐Ÿ‡บ๐Ÿ‡ธ USA
Titan Pharmaceuticals
TTNP
-โ‚ฌ2.41 Million-97.68%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
โ‚ฌ19.83 B-19,167.83%๐Ÿ‡บ๐Ÿ‡ธ USA